complementary and alternative medicine in hematologic disease: help or harm?
Published 3 years ago • 205 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:56
microbiota in hematologic malignancies
-
2:07
the microbiota: a new player in gvhd pathophysiology
-
0:58
hematological manifestations associated with primary immunodeficiency disorders
-
1:37
transplantation: a holistic approach
-
1:05
unmet needs in gvhd & the promise of regenerative medicine
-
2:38
cardiotoxicity associated with mcl-1 inhibition for r/r hematologic malignancies
-
0:57
the potential of the tsafinder tool in hematological oncology
-
2:24
prevalence of btk and plcγ2 mutations in cll relapsing under ibrutinib
-
3:35
role of the microbiome in gvhd
-
2:31
the structure of eric 2020 and the workshops available
-
3:48
trials of interest in newly diagnosed myeloma presented at ims 2024
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
1:51
thrombotic and bleeding complications in al amyloidosis
-
1:25
prognostic and predictive biomarkers in cll and their potential in guiding treatment decisions
-
1:21
what is the pcrowd study, and how does knowledge in myeloma biology help with new treatments?
-
1:37
the next steps and updated guidelines for the use of mrd concepts in multiple myeloma
-
1:17
novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax